So when you add that in, what do you get to? And when the improperly reported rev is subtracted out, well, we have to see what the amended Q states. It would be interesting to know if any pharmacies were operating and generating rev in the earlier part of last quarter. That wouldn’t reoccur. Hopefully we learn of dme-iq being brought to new clients besides the one and that the mso is now growing.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links